Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

BACKGROUND: Diabetes is a prognostic factor for some malignancies, but its association with outcome in patients with advanced or metastatic colorectal cancer (CRC) is less clear. METHODS: This cohort study was nested within a randomized trial of first-line chemotherapy and bevacizumab and/or cetuxim...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JNCI Cancer Spectr
Главные авторы: Brown, Justin C, Zhang, Sui, Ou, Fang-Shu, Venook, Alan P, Niedzwiecki, Donna, Lenz, Heinz-Josef, Innocenti, Federico, O’Neil, Bert H, Shaw, James E, Polite, Blase N, Denlinger, Crystal S, Atkins, James N, Goldberg, Richard M, Ng, Kimmie, Mayer, Robert J, Blanke, Charles D, O’Reilly, Eileen M, Fuchs, Charles S, Meyerhardt, Jeffrey A
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043296/
https://ncbi.nlm.nih.gov/pubmed/32259016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkz078
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы